
  
    
      
        Background_NNP
        Nearly_RB 1_CD ._. 2_CD billion_CD people_NNS are_VBP at_IN risk_NN of_IN developing_VBG
        lymphatic_JJ filariasis_NNS and_CC over_IN 128_CD million_CD are_VBP estimated_VBN to_TO
        have_VB circulating_VBG microfilariae_NN or_CC one_CD of_IN the_DT various_JJ
        clinical_JJ conditions_NNS associated_VBN with_IN filarial_NN infection_NN [_NN 1_CD
        ]_NN ._. With_IN tools_NNS currently_RB available_JJ ,_, lymphatic_JJ filariasis_NNS ,_,
        in_IN principle_NN ,_, could_MD be_VB eliminated_VBN ._. Combined_VBN drug_NN treatment_NN
        regimens_NNS using_VBG annual_JJ treatment_NN with_IN microfilaricidal_NN drugs_NNS
        are_VBP the_DT method_NN of_IN choice_NN for_IN combating_VBG filarial_NN infection_NN
        and_CC elimination_NN programs_NNS using_VBG this_DT strategy_NN have_VBP commenced_VBD
        in_IN more_JJR than_IN 30_CD countries_NNS [_NN 2_CD ]_NN ._.
        Demonstrating_NNP the_DT success_NN of_IN filariasis_NNS programs_NNS depends_VBZ
        on_IN careful_JJ monitoring_NN of_IN infection_NN levels_NNS in_IN human_JJ
        populations_NNS as_RB well_RB as_IN vectors_NNS following_VBG the_DT introduction_NN
        of_IN the_DT drug_NN intervention_NN ._. Due_JJ to_TO reluctance_NN on_IN the_DT part_NN of_IN
        human_JJ populations_NNS to_TO submit_VB to_TO regular_JJ blood_NN examinations_NNS ,_,
        assessment_NN of_IN infection_NN in_IN vectors_NNS offers_VBZ advantages_NNS for_IN
        the_DT monitoring_NN of_IN infection_NN after_IN a_DT mass_NN treatment_NN program_NN
        has_VBZ been_VBN implemented_VBN ._. Two_CD methods_NNS of_IN detecting_VBG infection_NN in_IN
        vector_NN populations_NNS that_WDT are_VBP now_RB being_VBG widely_RB used_VBN are_VBP
        dissection_NN and_CC PCR_NNP ._. Dissection_NNP has_VBZ been_VBN the_DT gold_NN standard_JJ
        for_IN measuring_VBG infection_NN level_NN in_IN mosquitoes_NNS ;_: however_RB ,_,
        dissection_NN becomes_VBZ increasingly_RB costly_JJ and_CC laborious_JJ in_IN
        areas_NNS where_WRB mosquito_NN infection_NN prevalence_NN drops_NNS below_IN 1_CD %_NN ._.
        Furthermore_RB ,_, in_IN preliminary_JJ studies_NNS ,_, PCR_NNP was_VBD more_RBR sensitive_JJ
        for_IN detecting_VBG filarial_NN parasites_NNS in_IN mosquitoes_NNS than_IN
        conventional_JJ dissection_NN and_CC microscopy_NN [_NN 3_CD ]_NN ._. The_DT ability_NN
        to_TO adapt_VB PCR_NNP techniques_NNS to_TO detect_VB microfilariae_NN in_IN pools_NNS of_IN
        mosquitoes_NNS suggests_VBZ that_IN current_JJ PCR_NNP methods_NNS should_MD be_VB
        adequate_JJ for_IN testing_VBG large_JJ numbers_NNS of_IN mosquitoes_NNS in_IN the_DT
        context_NN of_IN filariasis_NNS elimination_NN programs_NNS ._. PCR_NNP has_VBZ already_RB
        been_VBN demonstrated_VBN to_TO be_VB a_DT successful_JJ tool_NN for_IN monitoring_VBG
        onchocerciasis_NNS programs_NNS [_NN 4_CD 5_CD ]_NN ._. The_DT availability_NN of_IN such_JJ
        a_DT tool_NN permits_VBZ rigorous_JJ surveillance_NN for_IN resumption_NN of_IN
        transmission_NN following_VBG completion_NN of_IN control_NN
        activities_NNS ._.
        This_DT study_NN was_VBD designed_VBN to_TO monitor_VB mosquito_NN infection_NN
        levels_NNS in_IN conjunction_NN with_IN a_DT mass_NN treatment_NN program_NN for_IN
        filariasis_NNS in_IN the_DT commune_NN of_IN Leogane_NNP ,_, Haiti_NNP ._. The_DT goal_NN of_IN
        this_DT program_NN in_IN Leogane_NNP was_VBD to_TO develop_VB an_DT effective_JJ
        elimination_NN strategy_NN that_WDT could_MD be_VB adapted_VBN to_TO other_JJ
        settings_NNS in_IN Haiti_NNP and_CC elsewhere_RB ._. The_DT drug_NN intervention_NN
        consisted_VBD of_IN annual_JJ treatment_NN with_IN diethylcarbamazine_NN (_( DEC_NNP )_)
        and_CC albendazole_NN and_CC was_VBD monitored_VBN by_IN collecting_VBG data_NNS in_IN 4_CD
        well-characterized_JJ sentinel_NN sites_NNS ._. We_PRP assessed_VBD filarial_NN
        infection_NN rates_NNS of_IN vectors_NNS trapped_VBN in_IN the_DT 4_CD sentinel_NN sites_NNS
        and_CC compared_VBN PCR_NNP with_IN dissection_NN as_IN monitoring_VBG tools_NNS ._.
      
      
        Methods_NNP
        
          Study_NN site_NN
          The_DT study_NN was_VBD conducted_VBN in_IN the_DT plains_NNS of_IN the_DT Commune_NNP
          of_IN Leogane_NNP ,_, located_VBN west_NN of_IN Port_NNP au_NN Prince_NNP ._. To_TO monitor_VB
          the_DT impact_NN of_IN the_DT mass_NN treatment_NN program_NN ,_, sentinel_NN sites_NNS
          were_VBD chosen_VBN based_VBN on_IN estimated_VBN community_NN antigen_NN
          prevalence_NN inferred_VBN from_IN rapid_JJ card-based_JJ
          immunochromatographic_JJ testing_NN (_( ICT_NNP )_) of_IN local_JJ school_NN
          children_NNS (_( Amrad_NNP ICT_NNP ,_, New_NNP South_NNP Wales_NNP ,_, Australia_NNP )_) ._.
          Microfilaria_NNP prevalence_NN and_CC intensity_NN were_VBD assessed_VBN in_IN
          the_DT sentinel_NN sites_NNS prior_RB to_TO the_DT intervention_NN ._. Mass_NNP
          treatment_NN using_VBG single_JJ dose_NN diethylcarbamazine_NN (_( 6_CD mg_NN /_NN kg_NN )_)
          and_CC albendazole_NN (_( 400_CD mg_NN )_) was_VBD carried_VBN out_RB at_IN the_DT end_NN of_IN
          October_NNP 2000_CD ._. Details_NNS of_IN the_DT drug_NN distribution_NN will_MD be_VB
          reported_VBN elsewhere_RB ._. Research_NN activities_NNS in_IN the_DT sentinel_NN
          sites_NNS were_VBD reviewed_VBN and_CC approved_VBN by_IN the_DT CDC_NNP and_CC Notre_NNP
          Dame_NNP Institutional_NNP Review_NNP Boards_NNP ,_, and_CC the_DT Ethics_NNP
          Committee_NNP of_IN Hopital_NNP St_NNP ._. Croix_NNP ._.
        
        
          Mosquito_NNP Trapping_NNP
          The_DT main_JJ vector_NN for_IN 
          Wuchereria_NNP bancrofiti_NN in_IN Haiti_NNP is_VBZ 
          Culex_NNP quinquefasciatus_JJ [_NN 6_CD ]_NN ._. Some_DT
          transmission_NN occurs_VBZ year-round_JJ ._. The_DT trapping_VBG of_IN
          mosquitoes_NNS was_VBD done_VBN using_VBG CDC_NNP gravid_NN traps_NNS (_( Model_NNP 1712_CD ,_,
          J_NNP ._. W_NNP ._. Hock_NNP Co_NNP ._. ,_, Gainesville_NNP ,_, FL_NNP )_) ,_, 5_CD to_TO 6_CD per_IN sentinel_NN
          site_NN ._. Collections_NNP were_VBD done_VBN in_IN each_DT sentinel_NN site_NN for_IN 4_CD
          consecutive_JJ nights_NNS every_DT other_JJ week_NN ._. Mosquitoes_NNP were_VBD
          collected_VBN from_IN traps_NNS each_DT morning_NN within_IN 30_CD minutes_NNS of_IN
          dawn_NN ._. After_IN transport_NN to_TO the_DT laboratory_NN at_IN Hopital_NNP St_NNP ._.
          Croix_NNP ,_, mosquitoes_NNS were_VBD knocked_VBN down_RB by_IN placing_VBG trap_NN
          containers_NNS in_IN a_SYM -_: 20_CD °_NN C_NNP freezer_NN for_IN ten_CD minutes_NNS or_CC by_IN
          introduction_NN of_IN a_DT triethylamine-soaked_JJ cotton_NN pad_NN ,_, and_CC
          subsequently_RB separated_VBN by_IN species_NNS and_CC sex_NN ;_: undesired_JJ
          specimens_NNS were_VBD noted_VBN and_CC discarded_VBN (_( males_NNS and_CC non-vector_JJ
          species_NNS )_) ._. Female_NNP 
          Culex_NNP mosquitoes_NNS were_VBD divided_VBN 1_CD :_: 1_CD
          for_IN assay_NN by_IN PCR_NNP or_CC dissection_NN for_IN the_DT first_JJ 100_CD
          mosquitoes_NNS caught_VBN at_IN each_DT trap_NN ;_: the_DT remainder_NN was_VBD used_VBN
          for_IN PCR_NNP ._. The_DT samples_NNS to_TO be_VB used_VBN for_IN PCR_NNP assay_NN were_VBD
          desiccated_JJ and_CC sorted_VBN until_IN shipment_NN to_TO CDC_NNP for_IN
          processing_NN ._. Because_IN preliminary_JJ PCR_NNP experiments_NNS showed_VBD
          inhibition_NN to_TO be_VB an_DT occasional_JJ problem_NN when_WRB pool_NN sizes_NNS of_IN
          25_CD or_CC greater_JJR were_VBD used_VBN ,_, mosquitoes_NNS to_TO be_VB desiccated_JJ were_VBD
          sorted_VBN into_IN batches_NNS of_IN no_RB more_JJR than_IN 15_CD mosquitoes_NNS and_CC
          then_RB placed_VBN atop_IN a_DT cotton_NN plug_NN ,_, which_WDT was_VBD above_IN 1_CD /_NN 4_CD inch_NN
          of_IN drierite_NN desiccant_NN in_IN a_DT polypropylene_NN screw_NN cap_NN tube_NN ._.
          This_DT ensured_JJ desiccation_NN and_CC reduced_VBD any_DT concerns_NNS about_IN
          fungal_NN contamination_NN during_IN storage_NN and_CC transport_NN ._.
        
        
          Mosquito_NNP Dissection_NNP
          Mosquitoes_NNP were_VBD dissected_VBN on_IN a_DT glass_NN slide_NN using_VBG a_DT set_NN
          of_IN dissection_NN needles_NNS to_TO separate_VB the_DT head_NN ,_, thorax_NN ,_, and_CC
          abdomen_NN ._. A_DT saline_NN solution_NN was_VBD dropped_VBN onto_IN each_DT segment_NN ._.
          These_DT three_CD body_NN segments_NNS were_VBD then_RB teased_VBN apart_RB and_CC
          examined_VBD stereoscopically_RB to_TO reveal_VB larval_NN stage_NN worms_NNS or_CC
          microfilaria_NN ._. Mosquito_NNP infection_NN status_NN was_VBD noted_VBN as_RB well_RB
          as_IN the_DT corresponding_JJ location_NN of_IN the_DT parasites_NNS ._. Ten_CD
          percent_NN of_IN dissected_VBN mosquitoes_NNS harboring_VBG 3_CD rdstage_NN
          larvae_NN were_VBD microscopically_RB examined_VBN at_IN 100_CD ×_NN to_TO verify_VB
          filarial_NN species_NNS ._. A_DT maximum_NN of_IN 50_CD mosquitoes_NNS were_VBD
          dissected_VBN per_IN trap_NN per_IN day_NN ._. Dissection_NNP results_NNS were_VBD
          entered_VBN into_IN an_DT Epi-_NNP Info_NNP database_NN ._. Infective_NNP mosquitoes_NNS
          were_VBD defined_VBN as_IN those_DT containing_VBG L_NNP 3_CD larvae_NN in_IN any_DT of_IN the_DT
          body_NN segments_NNS ._. Mosquitoes_NNP carrying_VBG microfilaria_NN ,_, L_NNP 1_CD ,_, L_NNP 2_CD ,_,
          or_CC L_NNP 3_CD larvae_NN were_VBD defined_VBN as_IN infected_JJ ._.
        
        
          Extraction_NNP of_IN DNA_NNP
          DNA_NN extraction_NN for_IN PCR_NNP amplification_NN was_VBD performed_VBN as_IN
          described_VBN by_IN Chanteau_NNP et_CC al_NN ._. [_NN 7_CD ]_NN ._. Briefly_NNP ,_, the_DT dried_VBD
          pools_NNS of_IN mosquitoes_NNS were_VBD homogenized_JJ with_IN a_DT pellet_NN pestle_NN
          (_( Kimble_NNP /_NN Kontes_NNP ,_, Vineland_NNP ,_, NJ_NNP ,_, USA_NNP )_) and_CC 500_CD μl_NN of_IN NIB_NNP
          buffer_NN (_( 5_CD M_NNP NaCl_NNP ,_, 1_CD M_NNP Tris_NNP pH_NN 8_CD ,_, 0_CD ._. 5_CD M_NNP EDTA_NNP ,_, 0_CD ._. 07_CD %_NN
          β-mercaptoethanol_JJ ,_, 0_CD ._. 5_CD %_NN NP-_NNP 40_CD )_) in_IN a_DT 1_CD ._. 5_CD ml_NN eppendorf_NN tube_NN
          (_( Marsh_NNP Bio_NNP Products_NNPS ,_, Rochester_NNP ,_, NY_NNP ,_, USA_NNP )_) ._. The_DT extracted_VBN
          DNA_NNP was_VBD then_RB bound_VBN to_TO silica_NN beads_NNS (_( Sigma-_NNP Aldrich_NNP ,_, St_NNP ._.
          Louis_NNP ,_, MO_NNP ,_, USA_NNP )_) ._. The_DT beads_NNS were_VBD washed_VBN to_TO remove_VB
          inhibitors_NNS ._. After_IN washing_VBG ,_, the_DT silica_NN beads_NNS were_VBD dried_VBN
          and_CC the_DT DNA_NNP was_VBD then_RB eluted_JJ into_IN 100_CD μl_NN of_IN 1_CD X_NNP Tris-_NNP EDTA_NNP
          (_( 1_CD %_NN Tris_NNP ,_, 0_CD ._. 02_CD %_NN EDTA_NNP )_) ,_, pH_NN 8_CD ._.
        
        
          PCR_NNP Amplification_NNP
          The_DT PCR_NNP for_IN the_DT competitive_JJ ELISA_NNP analysis_NN was_VBD
          conducted_VBN using_VBG NV-_NNP 1_CD and_CC NV-_NNP 2_CD oligonucleotides_NNS specific_JJ
          for_IN the_DT 
          Ssp_NNP I_PRP repeat_NN as_RB previously_RB
          described_VBN by_IN Bockarie_NNP and_CC others_NNS [_NN 8_CD ]_NN ._. Amplification_NNP
          was_VBD performed_VBN with_IN an_DT Applied_NNP Biosystems_NNP 9700_CD PCR_NNP
          thermocycler_NN (_( Branchburg_NNP ,_, NJ_NNP ,_, USA_NNP )_) using_VBG 36_CD cycles_NNS with_IN
          Amplitaq_NNP gold_NN (_( Applied_NNP Biosystems_NNP Branchburg_NNP ,_, NJ_NNP ,_, USA_NNP )_) in_IN
          a_DT reaction_NN volume_NN of_IN 50_CD μl_NN ._. Included_VBN in_IN the_DT assays_NNS was_VBD
          100_CD fg_NN of_IN internal_JJ control_NN plasmid_NN [_NN 9_CD ]_NN (_( generously_RB
          provided_VBN by_IN Dr_NNP ._. Steven_NNP Williams_NNP of_IN Smith_NNP College_NNP )_) to_TO
          verify_VB amplification_NN ._. Primer_NNP NV-_NNP 2_CD was_VBD biotinylated_JJ to_TO
          facilitate_VB binding_VBG of_IN the_DT product_NN to_TO a_DT streptavidin_NN
          (_( Sigma-_NNP Aldrich_NNP )_) -_: coated_JJ microtiter_NN plate_NN (_( Immulon_NNP II_NNP
          Thermo_NNP Labsystems_NNP ,_, Franklin_NNP ,_, MA_NNP ,_, USA_NNP )_) ._. UV_NNP treated_VBD
          distilled_VBN water_NN without_IN internal_JJ control_NN was_VBD used_VBN as_IN a_DT
          negative_JJ control_NN ._. Positive_JJ control_NN DNA_NNP was_VBD derived_VBN from_IN
          parasites_NNS obtained_VBN from_IN microfilaria_NN infected_JJ
          individuals_NNS ._. Filarial_NNP DNA_NNP was_VBD extracted_VBN using_VBG a_DT DNAzol_NNP
          (_( Invitrogen_NNP ,_, Carlsbad_NNP ,_, CA_NNP ,_, USA_NNP )_) extraction_NN method_NN as_IN
          described_VBN by_IN the_DT manufacturer_NN ._.
        
        
          PCR-ELISA_NNP
          PCR_NNP products_NNS were_VBD detected_VBN by_IN ELISA_NNP as_IN per_IN protocols_NNS
          described_VBN by_IN Fischer_NNP and_CC others_NNS [_NN 9_CD ]_NN with_IN slight_JJ
          modifications_NNS described_VBD below_IN ._. PCR_NNP product_NN was_VBD added_VBN to_TO
          streptavidin-coated_JJ plates_NNS ._. The_DT initial_JJ volume_NN of_IN the_DT PCR_NNP
          product_NN (_( 50_CD μl_NN )_) was_VBD diluted_VBN to_TO a_DT total_JJ volume_NN of_IN 220_CD μl_NN
          with_IN hybridization_NN buffer_NN ._. Samples_NNP were_VBD tested_VBN at_IN 100_CD μl_NN
          per_IN well_RB and_CC were_VBD hybridized_JJ with_IN fluorescein-labeled_JJ
          probes_NNS specific_JJ for_IN wild_JJ type_NN or_CC internal_JJ control_NN
          sequences_NNS ._. Probes_NNP were_VBD hybridized_JJ to_TO plate_NN bound_VBN PCR_NNP
          products_NNS at_IN 55_CD °_NN C_NNP for_IN 30_CD minutes_NNS and_CC then_RB incubated_JJ
          alkaline_NN phosphatase-labelled_JJ anti-fluorescein_JJ Fab_NNP
          fragments_NNS (_( Roche_NNP Diagnostics_NNPS ,_, Indianapolis_NNP ,_, IN_IN )_) ._. Plates_NNP
          were_VBD sealed_VBN with_IN Falcon_NNP pressure_NN sensitive_JJ film_NN (_( Falcon_NNP
          Becton_NNP Dickinson_NNP ,_, Franklin_NNP Lakes_NNP ,_, NJ_NNP ,_, USA_NNP )_) at_IN all_DT assay_NN
          stages_NNS to_TO eliminate_VB any_DT potential_JJ contamination_NN between_IN
          wells_NNS ._. Plates_NNP were_VBD read_VBN on_IN a_DT Uvmax_NNP plate_NN reader_NN at_IN 405_CD nm_NN
          (_( Molecular_NNP Devices_NNPS ,_, Sunnyvale_NNP ,_, CA_NNP ,_, USA_NNP )_) after_IN 1_CD hr_NN
          development_NN with_IN substrate_NN ._. A_DT positive_JJ sample_NN was_VBD defined_VBN
          as_RB previously_RB described_VBD ,_, as_IN 5_CD times_NNS the_DT uncorrected_JJ
          optical_JJ density_NN (_( OD_NNP )_) of_IN a_DT sample_NN containing_VBG no_DT template_NN
          DNA_NNP ,_, but_CC with_IN 100_CD fg_NN of_IN internal_JJ control_NN [_NN 8_CD ]_NN ._. The_DT
          controls_NNS were_VBD designed_VBN to_TO allow_VB for_IN cutoff_NN determination_NN ,_,
          as_RB well_RB as_IN to_TO determine_VB the_DT success_NN of_IN the_DT PCR_NNP
          thermocycler_NN run_NN ._. Amplified_NNP high_JJ positive_JJ control_NN DNA_NNP
          (_( 0_CD ._. 1_LS μg_NN of_IN extracted_VBN 
          W_NNP ._. bancrofti_NN DNA_NNP )_) yielded_VBD an_DT almost_RB
          immediate_JJ response_NN by_IN ELISA_NNP and_CC low_JJ positive_JJ control_NN DNA_NNP
          (_( 0_CD ._. 01_CD μg_NN concentration_NN )_) provided_VBD a_DT low_JJ range_NN positive_JJ
          against_IN which_WDT to_TO compare_VB samples_NNS ._. Both_DT sample_NN positive_JJ
          controls_NNS were_VBD run_VBN with_IN and_CC without_IN 100_CD fg_NN of_IN internal_JJ
          control_NN to_TO monitor_VB the_DT level_NN of_IN competition_NN between_IN
          internal_JJ control_NN and_CC 
          W_NNP ._. bancrofti_NN template_NN DNA_NNP ._. Negative_JJ
          controls_NNS included_VBD water_NN with_IN and_CC without_IN 100_CD fg_NN of_IN
          internal_JJ control_NN and_CC DNA_NNP extracted_VBD from_IN a_DT pool_NN of_IN 15_CD
          parasite-negative_JJ lab-reared_JJ mosquitoes_NNS (_( 2_CD μl_NN of_IN
          extracted_VBN product_NN ,_, prepared_VBN in_IN parallel_JJ with_IN Haitian_JJ
          samples_NNS )_) ._. UV_NNP treated_VBD ,_, distilled_VBN ,_, deionized_JJ water_NN was_VBD used_VBN
          to_TO replace_VB the_DT volume_NN of_IN mosquito_NN DNA_NNP usually_RB present_JJ ._.
          This_DT sample_NN was_VBD run_VBN in_IN triplicate_NN ,_, along_IN with_IN all_DT other_JJ
          controls_NNS ._. In_IN conjunction_NN with_IN the_DT PCR_NNP controls_NNS ,_, the_DT
          microtiter_NN plates_NNS had_VBD a_DT plate_NN blank_JJ on_IN each_DT plate_NN that_WDT
          was_VBD 6_CD wells_NNS of_IN sample_NN buffer_NN hybridized_JJ with_IN either_DT wild_JJ
          probe_NN or_CC internal_JJ control_NN ._. Positive_JJ controls_NNS exhibited_VBN a_DT
          high_JJ degree_NN of_IN reproducibility_NN with_IN the_DT cutoff_NN as_IN
          established_VBN ._. The_DT high_JJ positive_JJ (_( 0_CD ._. 1_LS μg_NN 
          W_NNP ._. bancrofti_NN DNA_NNP )_) was_VBD 97_CD %_NN
          reproducible_JJ and_CC the_DT low_JJ positive_NN was_VBD positive_JJ for_IN 86_CD %_NN of_IN
          the_DT assays_NNS ._.
        
        
          Statistical_NNP Analysis_NNP
          Prevalence_NNP rates_NNS from_IN dissection_NN data_NNS were_VBD computed_JJ
          and_CC compared_VBN using_VBG Sudaan_NNP version_NN 8_CD ._. 0_CD (_( SUDAAN_NNP Statistical_NNP
          Software_NNP Center_NNP ,_, Research_NNP Triangle_NNP Park_NNP ,_, NC_NNP ,_, USA_NNP )_) ,_, which_WDT
          takes_VBZ into_IN consideration_NN the_DT correlation_NN of_IN multiple_JJ
          collections_NNS from_IN the_DT same_JJ location_NN over_IN time_NN ._. The_DT t-test_JJ
          was_VBD used_VBN for_IN rate_NN comparisons_NNS ._. The_DT Pearson_NNP correlation_NN
          coefficient_NN was_VBD used_VBN to_TO estimate_VB the_DT association_NN of_IN
          dissection_NN based_VBD prevalence_NN rates_NNS with_IN PCR_NNP based_VBN rates_NNS ._.
          PCR_NNP point_NN estimates_NNS were_VBD computed_JJ and_CC compared_VBN using_VBG
          Poolscreen_NNP 2_CD ._. 0_CD generously_RB provided_VBN by_IN Dr_NNP ._. Tom_NNP Unnasch_NNP and_CC
          Charles_NNP Katholi_NNP (_( The_DT University_NNP of_IN Alabama_NNP ,_, Birmingham_NNP )_) [_NN
          10_CD ]_NN ._.
        
      
      
        Results_NNS
        Baseline_NNP microfilaria_NN prevalence_NN in_IN the_DT human_JJ population_NN
        ranged_VBD from_IN 0_CD ._. 8_CD -_: 15_CD ._. 9_CD %_NN in_IN the_DT sentinel_NN sites_NNS (_( Table_NNP 1_LS )_) ._.
        Median_JJ microfilaria_NN level_NN ranged_VBD from_IN 5_CD to_TO 11_CD microfilaria_NN
        per_IN 20_CD μl_NN for_IN microfilaria-positive_JJ persons_NNS ._. Microfilaria_NNP
        intensity_NN did_VBD not_RB differ_VB significantly_RB by_IN sentinel_NN site_NN
        (_( Table_NNP 1_LS )_) ._. Mass_NNP treatment_NN with_IN DEC_NNP /_NN albendazole_NN took_VBD place_NN
        at_IN the_DT end_NN of_IN October_NNP 2000_CD and_CC tablets_NNS were_VBD taken_VBN by_IN 72_CD %_NN of_IN
        the_DT at_IN risk_NN population_NN [_NN 11_CD ]_NN ._. By_IN 9_CD months_NNS following_VBG
        treatment_NN ,_, microfilaria_NN prevalence_NN declined_VBD to_TO 3_CD %_NN ,_, 4_CD ._. 3_CD %_NN ,_,
        0_CD ._. 4_CD %_NN and_CC 6_CD %_NN in_IN Barrier_NNP Jeudi_NNP ,_, Masson_NNP /_NN Mathieu_NNP ,_, Mapou_NNP and_CC
        Leogane_NNP ,_, respectively_RB ._.
        To_TO monitor_VB the_DT impact_NN of_IN mass_NN treatment_NN on_IN filarial_NN
        infection_NN level_NN in_IN mosquitoes_NNS ,_, trapping_VBG was_VBD initiated_VBN in_IN
        August_NNP of_IN 2000_CD ,_, 3_CD months_NNS prior_RB to_TO mass_NN treatment_NN ._. Because_IN
        the_DT number_NN of_IN mosquitoes_NNS trapped_VBN and_CC percentage_NN of_IN infected_JJ
        mosquitoes_NNS varied_VBD from_IN month_NN to_TO month_NN ,_, results_NNS were_VBD pooled_VBN
        into_IN 3_CD -_: month_NN intervals_NNS for_IN analysis_NN ._. As_IN seen_VBN in_IN Figure_NN 1_CD ,_,
        total_JJ mosquito_NN infection_NN levels_NNS ,_, as_IN detected_VBN by_IN dissection_NN ,_,
        declined_VBD from_IN pre-treatment_JJ to_TO the_DT first_JJ post-treatment_JJ
        interval_NN in_IN all_DT 4_CD sites_NNS ;_: however_RB ,_, these_DT decreases_NNS were_VBD
        statistically_RB significant_JJ in_IN only_RB 2_CD of_IN the_DT sites_NNS ,_, Leogane_NNP
        and_CC Barrier_NNP Jeudi_NNP ._. With_IN the_DT exception_NN of_IN Mapou_NNP ,_, larval_NN
        infection_NN rates_NNS were_VBD lower_JJR in_IN the_DT second_NN than_IN in_IN the_DT first_JJ
        3_CD -_: month_NN time_NN interval_NN following_VBG treatment_NN ._. The_DT numbers_NNS of_IN
        L_NNP 3_CD larvae_NN recovered_VBD declined_VBN significantly_RB in_IN only_RB one_CD of_IN
        the_DT 4_CD sentinel_NN sites_NNS (_( Figure_NN 1_CD ,_, Table_NNP 2_LS )_) ._. If_IN we_PRP adopt_VBP a_DT
        more_RBR conservative_JJ definition_NN of_IN what_WP constitutes_VBZ an_DT
        infective_JJ mosquito_NN and_CC restrict_VB our_PRP$ analysis_NN to_TO those_DT with_IN
        L_NNP 3_CD found_VBD in_IN the_DT head_NN ,_, no_DT change_NN over_IN time_NN was_VBD observed_VBN ._. In_IN
        fact_NN ,_, only_RB 16_CD out_IN of_IN 9459_CD mosquitoes_NNS dissected_VBN had_VBD L_NNP 3_CD in_IN
        the_DT head_NN (_( Table_NNP 3_LS )_) ._.
        
        W_NNP ._. bancrofti_NN infection_NN of_IN 
        Culex_NNP mosquitoes_NNS was_VBD also_RB assessed_VBN by_IN
        PCR_NNP for_IN a_DT total_NN of_IN 1704_CD pools_NNS (_( median_JJ pool_NN size_NN =_SYM 7_CD )_)
        collected_VBN over_IN the_DT study_NN period_NN ._. Because_IN pool_NN sizes_NNS ranged_VBD
        from_IN 1_CD to_TO 15_CD ,_, we_PRP used_VBD Poolscreen_NNP 2_CD ._. 0_CD to_TO generate_VB point_NN
        estimates_NNS and_CC confidence_NN intervals_NNS for_IN the_DT level_NN of_IN
        filarial_NN infection_NN in_IN mosquitoes_NNS ._. As_IN seen_VBN in_IN Table_NNP 4_CD ,_, point_NN
        estimates_NNS of_IN 
        W_NNP ._. bancrofti_NN infection_NN prevalence_NN
        declined_VBD following_VBG mass_NN treatment_NN in_IN all_DT 4_CD -_: sentinel_NN sites_NNS ._.
        Because_IN of_IN the_DT relatively_RB wide_JJ confidence_NN intervals_NNS ,_,
        significant_JJ declines_NNS in_IN infection_NN prevalence_NN were_VBD observed_VBN
        in_IN only_RB Barrier_NNP Jeudi_NNP and_CC Leogane_NNP for_IN both_DT time_NN periods_NNS
        following_VBG treatment_NN ,_, mirroring_NN the_DT results_NNS obtained_VBN with_IN
        dissection_NN ._.
        We_PRP also_RB compared_VBD changes_NNS in_IN infection_NN prevalence_NN for_IN
        mosquito_NN pools_NNS of_IN constant_JJ size_NN (_( n_NN =_SYM 15_CD )_) collected_VBN in_IN the_DT
        Leogane_NNP sentinel_NN site_NN ._. The_DT other_JJ three_CD sentinel_NN sites_NNS did_VBD
        not_RB have_VB enough_JJ pools_NNS of_IN this_DT size_NN to_TO conduct_VB this_DT analysis_NN
        (_( Table_NNP 4_LS )_) ._. Infection_NNP prevalence_NN in_IN Leogane_NNP decreased_VBD from_IN
        4_CD ._. 5_CD %_NN pre-treatment_JJ to_TO 0_CD ._. 55_CD %_NN in_IN the_DT first_JJ three_CD months_NNS
        following_VBG treatment_NN and_CC to_TO 0_CD ._. 12_CD %_NN in_IN the_DT second_JJ time_NN period_NN
        (_( Figure_NN 2_LS )_) ._. These_DT numbers_NNS agree_VBP closely_RB with_IN those_DT
        generated_VBN when_WRB all_DT pools_NNS were_VBD included_VBN in_IN the_DT analysis_NN ._.
        There_EX was_VBD a_DT moderately_RB strong_JJ correlation_NN between_IN larval_NN
        infection_NN rates_NNS as_IN determined_VBN by_IN dissection_NN and_CC PCR_NNP (_( Figure_NN
        3_CD ;_: r_LS =_SYM 0_CD ._. 72_CD ,_, p_NN =_SYM 0_CD ._. 008_CD )_) ._.
      
      
        Discussion_NNP
        Careful_NNP monitoring_NN of_IN filarial_NN transmission_NN is_VBZ
        necessary_JJ ,_, both_DT to_TO make_NN programmatic_JJ decisions_NNS about_IN
        stopping_VBG mass_NN treatment_NN as_RB well_RB as_IN to_TO assist_VB with_IN
        certification_NN of_IN elimination_NN ._. Serologic_NNP tools_NNS for_IN
        assessment_NN of_IN exposure_NN to_TO the_DT parasite_NN are_VBP still_RB under_IN
        development_NN and_CC testing_NN ._. Assessing_NNP infection_NN in_IN humans_NNS can_MD
        be_VB considered_VBN a_DT "_'' lagging_VBG indicator_NN "_'' because_IN the_DT prepatent_NN
        period_NN may_MD extend_VB for_IN months_NNS after_IN infection_NN ._. In_IN contrast_NN ,_,
        entomologic_JJ measures_NNS of_IN filarial_NN infection_NN of_IN vectors_NNS
        provide_VBP "_'' real-time_JJ "_'' estimates_NNS of_IN filarial_NN transmission_NN ._. We_PRP
        compared_VBD dissection_NN and_CC PCR_NNP to_TO determine_VB their_PRP$ utility_NN as_IN
        monitoring_VBG tools_NNS for_IN filariasis_NNS elimination_NN programs_NNS ._.
        For_IN monitoring_VBG mosquito_NN infection_NN status_NN within_IN the_DT
        context_NN of_IN a_DT filariasis_NNS elimination_NN program_NN ,_, mosquito_NN
        dissection_NN has_VBZ been_VBN the_DT gold_NN standard_JJ against_IN which_WDT other_JJ
        methods_NNS are_VBP compared_VBN ._. Our_PRP$ dissection_NN results_NNS show_VBP a_DT marked_VBD
        decrease_NN in_IN infection_NN level_NN from_IN the_DT pre-treatment_JJ period_NN
        to_TO the_DT end_NN of_IN the_DT post-treatment_JJ study_NN period_NN in_IN 3_CD of_IN the_DT 4_CD
        sites_NNS that_IN we_PRP monitored_VBD (_( Figure_NN 1_LS )_) ._. The_DT exception_NN was_VBD
        Mapou_NNP ,_, which_WDT started_VBD and_CC ended_VBD the_DT study_NN with_IN almost_RB the_DT
        same_JJ infection_NN prevalence_NN in_IN the_DT mosquito_NN populations_NNS we_PRP
        collected_VBD ._. This_DT can_MD be_VB attributed_VBN to_TO the_DT smaller_JJR than_IN
        desired_VBN sample_NN of_IN mosquitoes_NNS captured_VBN (_( 379_CD pre-treatment_JJ
        and_CC 370_CD during_IN the_DT second_JJ post-treatment_JJ time_NN interval_NN )_) and_CC
        the_DT low_JJ infection_NN prevalence_NN that_IN we_PRP observed_VBD there_RB ._.
        Dissection_NNP and_CC PCR_NNP assays_NNS of_IN captured_VBN mosquitoes_NNS
        generated_VBD similar_JJ ,_, but_CC not_RB identical_JJ results_NNS ._. We_PRP observed_VBD a_DT
        positive_JJ correlation_NN between_IN larval_NN infection_NN rates_NNS
        determined_VBN by_IN these_DT two_CD methods_NNS (_( Figure_NN 3_LS )_) ._. The_DT proportion_NN
        of_IN positive_JJ pools_NNS detected_VBN by_IN PCR_NNP was_VBD ,_, as_IN expected_VBN ,_, higher_JJR
        than_IN that_DT obtained_VBN by_IN dissection_NN ,_, even_RB after_IN using_VBG the_DT
        PoolScreen_NNP program_NN to_TO calculate_VB a_DT point_NN estimate_NN of_IN
        infection_NN prevalence_NN ._. This_DT can_MD be_VB accounted_VBN for_IN by_IN the_DT
        increased_VBN sensitivity_NN that_WDT is_VBZ provided_VBN by_IN the_DT PCR_NNP assay_NN ,_,
        especially_RB for_IN detection_NN of_IN early_JJ larval_NN stages_NNS that_WDT are_VBP
        more_RBR difficult_JJ to_TO detect_VB by_IN dissection_NN ._. Independent_NNP of_IN the_DT
        method_NN used_VBD ,_, mass_NN treatment_NN led_VBN to_TO a_DT reduction_NN in_IN levels_NNS of_IN
        
        W_NNP ._. bancrofti_NN in_IN trapped_VBN mosquitoes_NNS as_IN
        assessed_VBN by_IN dissection_NN and_CC PCR_NNP ._. The_DT reductions_NNS evident_JJ via_IN
        dissection_NN were_VBD observed_VBN in_IN all_DT 4_CD sentinel_NN sites_NNS studied_VBN ,_,
        representing_VBG an_DT overall_JJ decrease_NN of_IN 60_CD ._. 8_CD %_NN from_IN the_DT
        pre-treatment_JJ levels_NNS to_TO the_DT final_JJ study_NN interval_NN 6_CD months_NNS
        post-treatment_JJ ._. The_DT decreases_NNS in_IN filaria-infected_JJ
        mosquitoes_NNS were_VBD comparable_JJ to_TO the_DT decreases_NNS in_IN microfilaria_NN
        prevalence_NN seen_VBN in_IN the_DT human_JJ populations_NNS in_IN the_DT sentinel_NN
        sites_NNS ._.
        Although_IN dissection_NN is_VBZ a_DT very_RB effective_JJ way_NN to_TO monitor_VB
        infection_NN prevalence_NN in_IN vector_NN populations_NNS ,_, it_PRP is_VBZ a_DT very_RB
        laborious_JJ method_NN for_IN monitoring_VBG infection_NN prevalence_NN that_WDT
        requires_VBZ highly_RB trained_VBN technicians_NNS and_CC can_MD be_VB cost_VBN
        intensive_JJ ._. Dissection_NNP is_VBZ most_RBS suitable_JJ for_IN monitoring_VBG
        mosquito_NN infection_NN levels_NNS when_WRB the_DT infection_NN level_NN in_IN the_DT
        mosquito_NN population_NN is_VBZ greater_JJR than_IN 1_CD %_NN ._. This_DT will_MD be_VB true_JJ
        in_IN early_JJ stages_NNS of_IN filariasis_NNS programs_NNS ._. The_DT decision_NN to_TO use_VB
        dissection_NN rather_RB than_IN PCR_NNP may_MD also_RB be_VB influenced_VBN by_IN the_DT
        trapping_VBG method_NN ._. Household_NNP collections_NNS may_MD yield_VB
        substantially_RB higher_JJR rates_NNS of_IN infected_JJ mosquitoes_NNS than_IN the_DT
        gravid_NN traps_NNS that_WDT were_VBD employed_VBN in_IN our_PRP$ study_NN ._. When_WRB
        infection_NN prevalence_NN declines_NNS below_IN 1_CD %_NN ,_, the_DT potential_NN for_IN
        missing_VBG mosquitoes_NNS infected_VBN with_IN the_DT earliest_JJS larval_NN stages_NNS
        and_CC for_IN misidentifying_VBG the_DT species_NNS of_IN filarial_NN larvae_NN found_VBD
        within_IN mosquitoes_NNS increases_NNS ._. Another_DT concern_NN pointed_VBD out_IN by_IN
        Burkot_NNP and_CC Ichimori_NNP [_NN 12_CD ]_NN is_VBZ that_IN ,_, as_IN infection_NN level_NN
        declines_NNS ,_, increasing_VBG numbers_NNS of_IN mosquitoes_NNS must_MD be_VB
        dissected_VBN in_IN order_NN to_TO demonstrate_VB a_DT significant_JJ decline_NN in_IN
        infection_NN prevalence_NN ._. This_DT is_VBZ especially_RB true_JJ for_IN infective_JJ
        larvae_NN ._. In_IN our_PRP$ study_NN ,_, the_DT numbers_NNS of_IN mosquitoes_NNS carrying_VBG
        infective_JJ larvae_NN ,_, as_IN detected_VBN by_IN dissection_NN ,_, were_VBD
        insufficient_JJ to_TO allow_VB for_IN an_DT adequate_JJ statistical_JJ analysis_NN
        of_IN changes_NNS in_IN infection_NN prevalence_NN ._. Monitoring_NN transmission_NN
        levels_NNS based_VBN on_IN levels_NNS of_IN infective_JJ larvae_NN may_MD not_RB be_VB
        feasible_JJ within_IN the_DT scope_NN of_IN lymphatic_JJ filariasis_NNS
        elimination_NN programs_NNS in_IN settings_NNS like_IN Leogane_NNP where_WRB 
        Culex_NNP is_VBZ the_DT vector_NN because_IN of_IN the_DT
        relative_JJ rarity_NN of_IN identifying_VBG infective_JJ mosquitoes_NNS ._. Lot_NN
        quality_NN assurance_NN methods_NNS may_MD provide_VB an_DT alternative_NN
        sampling_VBG strategy_NN that_WDT may_MD prove_VB useful_JJ for_IN demonstrating_VBG
        with_IN the_DT smallest_JJS possible_JJ number_NN of_IN mosquitoes_NNS that_WDT
        filarial_NN infection_NN is_VBZ below_IN a_DT pre-established_JJ threshold_NN [_NN
        13_CD ]_NN ._.
        PCR_NNP assays_NNS of_IN mosquitoes_NNS permit_VBP larger_JJR number_NN of_IN samples_NNS
        to_TO be_VB evaluated_VBN for_IN infection_NN prevalence_NN ._. PCR_NNP is_VBZ both_DT
        specific_JJ and_CC highly_RB sensitive_JJ for_IN the_DT detection_NN of_IN parasite_NN
        DNA_NNP ._. The_DT primary_JJ limitations_NNS are_VBP the_DT cost_NN and_CC the_DT need_NN for_IN
        a_DT well-equipped_JJ lab_NN ._. In_IN addition_NN ,_, PCR_NNP methods_NNS are_VBP also_RB
        limited_VBN by_IN a_DT lack_NN of_IN robust_JJ statistical_JJ methods_NNS to_TO compare_VB
        and_CC analyze_VB data_NNS obtained_VBN from_IN unequal_JJ pool_NN sizes_NNS ._. Although_IN
        confidence_NN intervals_NNS of_IN infection_NN before_IN and_CC after_IN
        treatment_NN were_VBD overlapping_VBG for_IN 2_CD of_IN the_DT sentinel_NN sites_NNS ,_, it_PRP
        is_VBZ important_JJ to_TO point_VB out_IN that_IN confidence_NN intervals_NNS were_VBD
        not_RB overlapping_VBG for_IN the_DT two_CD locations_NNS where_WRB dissection_NN data_NNS
        indicated_VBD significant_JJ declines_NNS in_IN larval_NN prevalence_NN ._.
        We_PRP used_VBD a_DT competitive_JJ PCR_NNP system_NN in_IN order_NN to_TO control_VB for_IN
        the_DT presence_NN of_IN inhibitors_NNS that_WDT could_MD prevent_VB amplification_NN
        and_CC detection_NN of_IN parasite_NN DNA_NNP ._. The_DT disadvantage_NN of_IN the_DT
        competitive_JJ PCR_NNP is_VBZ the_DT need_NN to_TO use_VB an_DT ELISA_NNP assay_NN to_TO
        quantify_VB the_DT product_NN and_CC the_DT competitor_NN ,_, adding_VBG to_TO the_DT cost_NN
        of_IN the_DT assay_NN ._. Work_NN underway_NN is_VBZ focused_VBN on_IN trying_VBG to_TO develop_VB
        a_DT standardized_JJ PCR_NNP methodology_NN for_IN all_DT filariasis_NNS programs_NNS
        to_TO employ_VB [_NN 14_CD ]_NN ._. Simple_NN standardized_JJ methods_NNS would_MD permit_VB
        comparisons_NNS of_IN infection_NN levels_NNS across_IN epidemiologic_JJ
        settings_NNS as_IN has_VBZ been_VBN done_VBN with_IN PCR_NNP assays_NNS for_IN 
        O_NNP ._. volvulus_JJ in_IN black_JJ flies_NNS for_IN
        Onchocerciasis_NNP control_NN programs_NNS [_NN 4_CD 5_CD ]_NN ._. PCR_NNP methods_NNS for_IN
        onchocerciasis_NNS work_VBP reliably_RB for_IN pools_NNS of_IN up_IN to_TO 100_CD fly_VB
        heads_VBZ ,_, an_DT important_JJ advantage_NN in_IN terms_NNS of_IN cost_NN and_CC
        throughput_NN ._. As_IN similar_JJ methods_NNS are_VBP validated_JJ for_IN lymphatic_JJ
        filariasis_NNS ,_, it_PRP is_VBZ important_JJ to_TO bear_VB in_IN mind_NN that_DT assay_NN
        sensitivity_NN will_MD decline_VB as_IN filarial_NN infection_NN prevalence_NN
        decreases_NNS ,_, independent_JJ of_IN the_DT method_NN used_VBN to_TO detect_VB 
        W_NNP ._. bancrofti_NN ._. Consequently_RB ,_, quality_NN
        control_NN considerations_NNS will_MD become_VB more_RBR important_JJ as_IN the_DT
        program_NN progresses_VBZ ._. WHO_WP should_MD consider_VB distribution_NN of_IN
        controls_NNS to_TO laboratories_NNS involved_VBN in_IN PCR_NNP testing_NN to_TO permit_VB
        inter-laboratory_JJ comparisons_NNS of_IN results_NNS ._. Periodic_NNP
        proficiency_NN testing_NN represents_VBZ an_DT additional_JJ
        possibility_NN ._.
        A_DT main_JJ concern_NN of_IN mass_NN treatment_NN programs_NNS is_VBZ whether_IN or_CC
        not_RB the_DT decreases_NNS in_IN transmission_NN will_MD be_VB sustainable_JJ over_IN
        time_NN and_CC will_MD eliminate_VB completely_RB transmission_NN of_IN
        microfilaria_NN to_TO mosquitoes_NNS ._. Although_IN infection_NN levels_NNS were_VBD
        decreased_VBN ,_, transmission_NN of_IN 
        W_NNP ._. bancrofti_NN was_VBD not_RB interrupted_VBN by_IN a_DT
        single_JJ cycle_NN of_IN mass_NN treatment_NN in_IN our_PRP$ study_NN ._. This_DT is_VBZ not_RB
        surprising_VBG given_VBN the_DT intensity_NN of_IN transmission_NN in_IN this_DT
        setting_VBG and_CC the_DT modest_JJ coverage_NN in_IN the_DT first_JJ round_NN ._.
        Additional_JJ follow_VB up_RB will_MD be_VB necessary_JJ to_TO determine_VB how_WRB
        many_JJ cycles_NNS of_IN mass_NN treatment_NN will_MD be_VB necessary_JJ to_TO achieve_VB
        interruption_NN of_IN transmission_NN in_IN Leogane_NNP ._. These_DT results_NNS will_MD
        have_VB important_JJ implications_NNS for_IN the_DT length_NN of_IN lymphatic_JJ
        filariasis_NNS elimination_NN programs_NNS ._.
      
      
        Competing_VBG Interests_NNP
        None_NN declared_VBD
      
      
        Authors_NNP '_'' Contributions_NNP
        PJL_NNP and_CC TGS_NNP designed_VBD and_CC coordinated_VBN the_DT study_NN ,_, JNO_NNP
        collected_VBD samples_NNS and_CC oversaw_VBD dissections_NNS ,_, DSG_NNP conducted_VBD
        PCR_NNP assays_NNS ,_, data_NNS analysis_NN ,_, data_NNS entry_NN ,_, and_CC JMR_NNP performed_VBD
        the_DT statistical_JJ analysis_NN ._.
      
    
  
